ArticleClinical pharmacokinetics2025

A Population Pharmacokinetic Analysis for Piperacillin/Tazobactam in Patients with End-Stage Kidney Disease Undergoing Intermittent Haemodialysis: Extension of a General-Purpose Model.

D Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.